Oral Minoxidil for Alopecia in Systemic Sclerosis, Dermatomyositis, Mixed Connective Tissue Disease, and Undifferentiated Connective Tissue Disease: A Retrospective Cohort Study on Cardiovascular Risk

Overall patient demographics, connective tissue disease characteristics, oral minoxidil characteristics, and cardiovascular risk factors and outcomes from retrospective study examining cardiovascular risk of oral minoxidil for alopecia in systemic sclerosis, dermatomyositis, mixed connective tissue disease, and undifferentiated connective tissue disease.